Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Biorxiv : the Preprint Server for Biology|July 28, 2023
NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancerJia J Li, Alessandro Vasciaveo, Dimitrios Karagiannis, et al.
The Journal of Urology|July 16, 2017
Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical NephroureterectomyMalte Rieken, Shahrokh F Shariat, Jose A Karam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Molecular Oncology|March 23, 2026
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancerJennie N Jeyapalan, Veronika M Metzler, Simone de Brot, et al.
European Urology Focus|May 4, 2021
Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2Patrick Leo, Sacheth Chandramouli, Xavier Farré, et al.
World Journal of Urology|October 27, 2014
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomyRomain Mathieu, Shahrokh F Shariat, Christian Seitz, et al.
BJU International|September 24, 2013
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasisNiccolo M Passoni, Harun Fajkovic, Evanguelos Xylinas, et al.
BJU International|July 21, 2015
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation studyRomain Mathieu, Tobias Klatte, Ilaria Lucca, et al.
The Journal of Clinical Investigation|July 18, 2024
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancerSheng-Yu Ku, Yanqing Wang, Maria Mica Garcia, et al.
Urologic Oncology|August 1, 2015
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional studyRomain Mathieu, Tobias Klatte, Vitaly Margulis, et al.
Pageof 15